Author

Matthew J. O’Hern

Observed names: Matthew J O’Hern, Matthew J. O'Hern, Matthew O'Hern, Matthew O’Hern

Institution: The Ohio State University

Observed institutions: Washington University in St. Louis, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University

OpenAlex ID: A5059629119

Patterns ofCTCFandZFHX3Mutation and Associated Outcomes in Endometrial Cancer

2015 · Christopher J. Walker, Mario A. Miranda, et al. · JNCI Journal of the National Cancer Institute · 47

NovelSOX17frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutations

2017 · Christopher J. Walker, Matthew J. O'Hern, et al. · Oncotarget · 19

MAX Mutations in Endometrial Cancer: Clinicopathologic Associations and Recurrent MAX p.His28Arg Functional Characterization

2017 · Christopher J Walker, Craig M Rush, et al. · JNCI Journal of the National Cancer Institute · 11

MonoSeq Variant Caller Reveals Novel Mononucleotide Run Indel Mutations in Tumors with Defective DNA Mismatch Repair

2016 · Christopher J. Walker, Mario A. Miranda, et al. · Human Mutation · 7

Abstract 2002: MAX mutations in endometrial cancer are associated with poor patient outcome, altered E-box binding, and increased tumor vascularity

2016 · Christopher J. Walker, Craig Rush, et al. · Cancer Research

Abstract 5300: Loss of function of two closely linked tumor suppressors contributes to biologic aggressiveness in endometrial cancers: Co-mutation of CTCF and ZFHX3

2015 · Christopher J. Walker, Mario A. Miranda, et al. · Cancer Research

Works count: 6

Citation count: 84

H-index: 4

I10-index: 3